Craft

Advanced
GigaGen

GigaGen

Total Funding

$37.6 M

GigaGen Summary

Company Summary

Overview
GigaGen is a company developing antibody therapies to treat cancer and diseases of immune dysregulation. Its pipeline includes oncology antibody drug combinations and a recombinant polyclonal hyperimmune gammaglobulin.
Type
Private
Status
Active
Founded
2010
Website
https://www.gigagen.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Adam Adler

    Adam Adler, Chief Scientific Officer

    • Catherine Medina

      Catherine Medina, Vice President, Operations

      • Rena Mizrahi

        Rena Mizrahi, Vice President, Process Development

        • Jan Fredrik Simons

          Jan Fredrik Simons, Senior Director, Technology

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2025
          Share price data provided by IEX